The Glucose Sensor That Predicts the Future with Mark Tapsak
In this episode, Henry Norton sits down with Mark Tapsak, Chief Science Officer at Glucotrack and one of Dexcom's earliest employees.
Mark Tapsak left Medtronic for a "crazy startup" called Dexcom after seeing data so compelling he couldn't say no. Two decades later, he's back in the CGM game as Chief Science Officer at Glucotrack, working on a 3-year implantable sensor that lives in the bloodstream.
Key Topics:
Mark's path from blue-collar Minnesota to polymer chemistry PhD
The founding days of Dexcom and the "three fathers" of CGM (Goff, Updike, Heller)
Why early CGM struggled to convince…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.